A double‐blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
- 1 September 1984
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 18 (3), 461-462
- https://doi.org/10.1111/j.1365-2125.1984.tb02491.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984
- Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostateJournal of Steroid Biochemistry, 1984
- The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious ratsBritish Journal of Pharmacology, 1983
- The pathogenesis of benign prostatic hyperplasiaAmerican Journal Of Medicine, 1980
- ENDOGENOUS STEROID LEVELS IN THE HUMAN PROSTATE FROM BIRTH TO OLD AGE: A COMPARISON OF NORMAL AND DISEASED TISSUESJournal of Endocrinology, 1978
- Dihydrotestosterone in prostatic hypertrophyJCI Insight, 1970